Kerem Erden

Kerem Erden is a seasoned pharmaceutical and biotechnology executive with expertise in business development, licensing, and open innovation across the EMEA region. They previously held roles at Pfizer as a Field Force Effectiveness Specialist and Product Manager, while at Bayer Pharmaceuticals, Kerem served as Vice President & Head of the Collaborate2Cure Hub EMEA, overseeing business development and licensing initiatives. With a strong focus on cardiovascular, rare diseases, and cell/gene therapy, they have successfully driven multi-billion euro mergers and acquisitions, as well as product launches and commercialization strategies. Kerem holds an MSc in Project Management and Operational Development from KTH Royal Institute of Technology and a bachelor's degree in Electronics Engineering from Istanbul Technical University.